Target intelligence / Profile preview

Mitogen-activated protein kinase kinase kinase 15 (MAP3K15)

Target
MAP3K15
Molecular classification
Enzyme, Serine/threonine kinase, Kinase, Mitogen-activated protein kinase kinase kinase family
01

Overview

Mitogen-activated protein kinase kinase kinase 15 (MAP3K15, also known as ASK3) is a member of the MAP kinase kinase kinase family of serine/threonine kinases. It acts as an upstream regulator in the stress-activated MAPK signaling cascade, leading to activation of downstream kinases such as p38 MAPK. MAP3K15 is involved in signal transduction in response to various cellular stresses, playing essential roles in apoptosis, cell death, and osmoregulation, particularly in the kidney where it participates in the WNK1-SPAK/OSR1 pathway linked to blood pressure control. Genetic studies have identified protein-truncating variants in MAP3K15 as protective against type 1 and type 2 diabetes, with expression also correlated with immune interactions and cancer prognosis (notably in osteosarcoma). Overall, MAP3K15 integrates cellular responses to stress, inflammation, and osmotic changes, and is considered a potential therapeutic target across diseases such as diabetes, hypertension, and cancer.

Other names
ASK3BA723P2.3M3K15_HUMAN
02

Mechanism of action

Upstream activation of p38 MAPK cascade; Phosphorylation and activation of MAP kinase kinases (MAP2Ks); Regulation of WNK1–SPAK/OSR1 pathway (blood pressure/osmotic stress)

03

Biological functions

Signal transductionApoptosisCellular stress responseOsmoregulationCell deathPhosphorylation
04

Disease associations

Diabetes (type 1 and type 2, protective variant effects)Hypertension (blood pressure regulation)Cancer (prognostic role in osteosarcoma)Potential roles in kidney injury
05

Safety considerations

No significant adverse phenotypes with protein-truncating variants in human population studiesPotential need for caution regarding effects on apoptosis and blood pressure
06

Biomarkers

Prognostic biomarker in osteosarcoma (immune cell infiltration, especially CD4+ T cell correlation)Genetic variants predictive of diabetes risk (protective protein-truncating variants)

Beyond the preview

Go deeper on Mitogen-activated protein kinase kinase kinase 15 (MAP3K15).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitogen-activated protein kinase kinase kinase 15 (MAP3K15).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call